Personalized cancer treatment: test predicts which drugs will work before treatment starts
NCT ID NCT03877796
Summary
This study is testing a method to predict which cancer drugs will work best for individual ovarian cancer patients. Researchers will analyze tumor tissue samples from 60 patients with advanced ovarian cancer that has stopped responding to standard treatments. The goal is to create a tool that can tell doctors which experimental drugs are most likely to help each patient before they start treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beatson West of Scotland Cancer Centre
ACTIVE_NOT_RECRUITINGGlasgow, Scotland, G12 0YN, United Kingdom
-
Dana-Farber Cancer Institute
COMPLETEDBoston, Massachusetts, 02215, United States
-
Guy's and St Thomas' NHS Foundation Trust, Guy's Hospital
ACTIVE_NOT_RECRUITINGLondon, United Kingdom
-
OU Health Stephenson Cancer Center
RECRUITINGOklahoma City, Oklahoma, 73104, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Swedish Center for Research and Innovation
RECRUITINGSeattle, Washington, 98122, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.